v3.26.1
Segments (Tables)
6 Months Ended
Jun. 30, 2026
Segments [Abstract]  
Segment Data Segment data for the three months ended June 30, 2026 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

443,341 

$

229,910 

$

673,251 

$

-

$

673,251 

Cost of services provided and goods sold

(excluding depreciation)

Wages

254,425 

78,661 

333,086 

-

333,086 

Patient care expense

47,108 

-

47,108 

-

47,108 

Other expenses

36,158 

35,428 

71,586 

-

71,586 

Total cost of services provided and goods sold

337,691 

114,089 

451,780 

-

451,780 

Selling, general and administrative expense

Wages

17,959 

22,660 

40,619 

5,325 

45,944 

Advertising

-

21,793 

21,793 

-

21,793 

Stock compensation

-

-

-

11,300 

11,300 

Other expenses

8,146 

22,920 

31,066 

5,100 

36,166 

Total selling, general and administrative expense

26,105 

67,373 

93,478 

21,725 

115,203 

Depreciation

5,781 

8,474 

14,255 

12 

14,267 

Amortization

27 

2,692 

2,719 

-

2,719 

Other operating expense

28 

50 

78 

-

78 

Total costs and expenses

369,632 

192,678 

562,310 

21,737 

584,047 

Income/(loss) from operations

73,709 

37,232 

110,941 

(21,737)

89,204 

Interest expense

(54)

(185)

(239)

(1,550)

(1,789)

Intercompany interest income/(expense)

6,480 

4,575 

11,055 

(11,055)

-

Other income - net

66 

10 

76 

3,838 

3,914 

Income/(expense) before income taxes

80,201 

41,632 

121,833 

(30,504)

91,329 

Income taxes

(19,290)

(9,719)

(29,009)

5,383 

(23,626)

Net income/(loss)

$

60,911 

$

31,913 

$

92,824 

$

(25,121)

$

67,703 

Additions to long-lived assets

$

6,579 

$

21,962 

$

28,541 

$

4 

$

28,545 


Segment data for the three months ended June 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

396,201 

$

222,597 

$

618,798 

$

-

$

618,798 

Cost of services provided and goods sold

(excluding depreciation)

Wages

241,805 

75,704 

317,509 

-

317,509 

Patient care expense

41,008 

-

41,008 

-

41,008 

Other expenses

37,831 

37,757 

75,588 

-

75,588 

Total cost of services provided and goods sold

320,644 

113,461 

434,105 

-

434,105 

Selling, general and administrative expense

Wages

16,757 

21,018 

37,775 

2,748 

40,523 

Advertising

-

18,943 

18,943 

-

18,943 

Stock compensation

-

-

-

10,069 

10,069 

Other expenses

8,328 

20,575 

28,903 

1,885 

30,788 

Total selling, general and administrative expense

25,085 

60,536 

85,621 

14,702 

100,323 

Depreciation

5,314 

8,363 

13,677 

12 

13,689 

Amortization

26 

2,545 

2,571 

-

2,571 

Other operating expense/(income)

55 

(29)

26 

-

26 

Total costs and expenses

351,124 

184,876 

536,000 

14,714 

550,714 

Income/(loss) from operations

45,077 

37,721 

82,798 

(14,714)

68,084 

Interest expense

(47)

(129)

(176)

(267)

(443)

Intercompany interest income/(expense)

5,454 

3,970 

9,424 

(9,424)

-

Other income - net

61 

23 

84 

3,390 

3,474 

Income/(expense) before income taxes

50,545 

41,585 

92,130 

(21,015)

71,115 

Income taxes

(12,326)

(9,671)

(21,997)

3,375 

(18,622)

Net income/(loss)

$

38,219 

$

31,914 

$

70,133 

$

(17,640)

$

52,493 

Additions to long-lived assets

$

7,060 

$

8,745 

$

15,805 

$

5 

$

15,810 


Segment data for the first six months ended June 30, 2026 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

863,358 

$

467,406 

$

1,330,764 

$

-

$

1,330,764 

Cost of services provided and goods sold

(excluding depreciation)

Wages

498,530 

160,333 

658,863 

-

658,863 

Patient care expense

92,953 

-

92,953 

-

92,953 

Other expenses

71,674 

70,039 

141,713 

-

141,713 

Total cost of services provided and goods sold

663,157 

230,372 

893,529 

-

893,529 

Selling, general and administrative expense

Wages

35,195 

45,545 

80,740 

10,004 

90,744 

Advertising

-

43,833 

43,833 

-

43,833 

Stock compensation

-

-

-

22,055 

22,055 

Other expenses

17,018 

45,924 

62,942 

9,950 

72,892 

Total selling, general and administrative expense

52,213 

135,302 

187,515 

42,009 

229,524 

Depreciation

11,693 

16,853 

28,546 

24 

28,570 

Amortization

53 

5,236 

5,289 

-

5,289 

Other operating expense/(income)

80 

(9)

71 

(1)

70 

Total costs and expenses

727,196 

387,754 

1,114,950 

42,032 

1,156,982 

Income/(loss) from operations

136,162 

79,652 

215,814 

(42,032)

173,782 

Interest expense

(104)

(321)

(425)

(1,876)

(2,301)

Intercompany interest income/(expense)

12,717 

9,088 

21,805 

(21,805)

-

Other income - net

161 

25 

186 

8,502 

8,688 

Income/(expense) before income taxes

148,936 

88,444 

237,380 

(57,211)

180,169 

Income taxes

(35,818)

(20,747)

(56,565)

10,401 

(46,164)

Net income/(loss)

$

113,118 

$

67,697 

$

180,815 

$

(46,810)

$

134,005 

Additions to long-lived assets

$

13,322 

$

53,057 

$

66,379 

$

25 

$

66,404 


Segment data for the first six months ended June 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

803,600 

$

462,141 

$

1,265,741 

$

-

$

1,265,741 

Cost of services provided and goods sold

(excluding depreciation)

Wages

476,978 

153,176 

630,154 

-

630,154 

Patient care expense

81,387 

-

81,387 

-

81,387 

Other expenses

75,086 

78,008 

153,094 

-

153,094 

Total cost of services provided and goods sold

633,451 

231,184 

864,635 

-

864,635 

Selling, general and administrative expense

Wages

34,284 

42,204 

76,488 

7,479 

83,967 

Advertising

-

37,112 

37,112 

-

37,112 

Stock compensation

-

-

-

21,817 

21,817 

Other expenses

17,340 

43,868 

61,208 

1,806 

63,014 

Total selling, general and administrative expense

51,624 

123,184 

174,808 

31,102 

205,910 

Depreciation

10,509 

16,601 

27,110 

24 

27,134 

Amortization

52 

5,091 

5,143 

-

5,143 

Other operating expense/(income)

119 

(42)

77 

-

77 

Total costs and expenses

695,755 

376,018 

1,071,773 

31,126 

1,102,899 

Income/(loss) from operations

107,845 

86,123 

193,968 

(31,126)

162,842 

Interest expense

(95)

(261)

(356)

(416)

(772)

Intercompany interest income/(expense)

10,750 

7,900 

18,650 

(18,650)

-

Other income - net

110 

32 

142 

4,577 

4,719 

Income/(expense) before income taxes

118,610 

93,794 

212,404 

(45,615)

166,789 

Income taxes

(30,361)

(21,936)

(52,297)

9,758 

(42,539)

Net income/(loss)

$

88,249 

$

71,858 

$

160,107 

$

(35,857)

$

124,250 

Additions to long-lived assets

$

11,384 

$

18,186 

$

29,570 

$

5 

$

29,575 

Identifiable Assets By Segment

June 30,

December 31,

2026

2025

VITAS

$

796,653 

$

784,927 

Roto-Rooter

584,356 

528,587 

Reportable segments

1,381,009 

1,313,514 

Corporate

198,576 

224,675 

Chemed consolidated

$

1,579,585 

$

1,538,189